Stocks股票 / Health Care / TECH
TECH US listed · USD美股 · 美元
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司,为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
Price chart价格图表
Technicals技术面
daily bars日线数据 · 2026-07-21Earnings财务业绩
next report下次财报 2026-08-05Estimates being cut预期下调
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | TECH | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(历史) | 152.14x | 28.59 | |
| P/B市净率 | 5.55x | 3.44 | |
| P/S市销率 | 9.16x | 2.97 | |
| Earnings yield盈利收益率 | 0.66% | 2.72 | |
| FCF yield自由现金流收益率 | 2.30% | 4.00 | |
| Shareholder yield股东收益率 | 2.92% | 1.89 | |
| EV/EBITDA企业价值/EBITDA | 51.87x | 18.18 | |
| P/FCF市值/自由现金流 | 43.53x | 22.08 |
Financials财务数据
fiscal years财年Leverage杠杆
Capital allocation资本配置
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向: -$0.1M net (0 buyers, 1 sellers)-$0.1M 净值(0 买家,1 卖家)
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Durable Capital Partners | B | Adding加仓 | 2.4% | 2026-03-31 |
Signal history信号历史
engine events引擎事件Company profile公司档案
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.Bio-Techne公司是一家美国生命科学公司,为研究、诊断和生物加工市场开发、制造并销售生命科学试剂、仪器和服务。
- Margin compression despite revenue growth
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率(静态) | 152.1× | 28.6× | 3% |
| Price / Book市净率 | 5.5× | 3.4× | 28% |
| Price / Sales市销率 | 9.2× | 3.0× | 12% |
| EV / EBITDAEV/EBITDA | 51.9× | 18.2× | 13% |
| Earnings yield盈利收益率 | 0.7% | 2.7% | 28% |
| Free-cash-flow yield自由现金流收益率 | 2.6% | 5.5% | 21% |
| Shareholder yield股东综合回报率 | 2.9% | 1.9% | 64% |
Relative strength相对强度
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | +0.4% | -0.9% |
| 1 Month近1月 | +23.6% | -0.6% |
| 3 Months近3月 | +20.3% | +5.4% |
| 6 Months近6月 | +0.7% | +8.6% |
| Year to date年初至今 | +20.5% | +8.9% |
| 1 Year近1年 | +38.5% | +19.2% |
Trading information交易信息
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $739M | $931M | $1.1B | $1.1B | $1.2B | $1.2B |
| EPS每股收益 | $5.82 | $3.47 | $6.63 | $1.76 | $1.05 | $0.46 |
| Free cash flow自由现金流 | $153M | $308M | $280M | $216M | $236M | $257M |
| Gross margin毛利率 | 65.4% | 68.0% | 68.4% | 67.7% | 66.4% | 64.8% |
| Net margin净利率 | 31.0% | 15.1% | 24.6% | 25.1% | 14.5% | 6.0% |
| FCF margin自由现金流利润率 | 20.8% | 33.1% | 25.4% | 19.0% | 20.4% | 21.0% |
Latest fiscal year最近财年
Returns & growth回报与增长
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量:盈利有现金支撑
- Working capital: working capital roughly in line with sales营运资本:营运资本与销售大致同步
- Pricing power: gross margin −0.6pts over 6 years定价能力:毛利率 6 年下降 0.6 个百分点
- Capital discipline: share count +303.0% over 6 years (dilution)资本纪律:股本 6 年增加 303.0%(稀释)
- Balance sheet: Altman Z 11.88 — safe zone资产负债表:Altman Z 11.88——安全区
Indicator readings指标读数
Timeframe alignment多周期共振
Volatility regime波动状态
Estimate revisions预期修正
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Durable Capital Partners | B | Adding增持 | 2.4% | $233M |